Why the study?
The hemodynamic and cardiovascular impacts of coffee and caffeine remain controversial, creating a need to clarify their cardiovascular effects and drug interactions in patients after acute coronary syndrome.
Does coffee and caffeine consumption affect cardiovascular outcomes or interact with common medications in patients with a history of acute coronary syndrome?
Does coffee and caffeine consumption affect cardiovascular outcomes or interact with common medications in patients with a history of acute coronary syndrome?
Moderate caffeine consumption appears safe post-ACS, but potential interactions with statins warrant further investigation.
Answers are grounded in this paper and cite their sources.
Supports hypothesis of safe moderate caffeine use post-ACS; leaves open RCTs on medication interactions.
The hemodynamic and cardiovascular impacts of coffee and caffeine have long been controversial. However, due to the worldwide popularity of coffee and caffeinated beverages, it is essential to understand how they affect the cardiovascular system, specifically in patients with a history of acute coronary syndrome. This literature review was conducted to explore the cardiovascular effects of coffee and caffeine and their interactions with common drugs after acute coronary syndrome and percutaneous coronary intervention. The evidence suggests that moderate coffee and caffeine consumption is not associated with cardiovascular disease in healthy individuals and patients with a history of acute coronary syndrome. The interactions of coffee or caffeine with common medications after acute coronary syndrome or percutaneous coronary intervention are less studied. However, based on the current human studies in this field, the only interaction is with the protective effect of statins on cardiac ischemia.
No takes yet. Share an insight, caveat, or question.
Yaghoobian et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: